Ultimovacs ASA: Mandatory notification of trade by primary insider
This information is subject to the disclosure requirements pursuant to the Market Abuse Regulation article 19 and section 5-12 of the Norwegian Securities Trading Act. Attachment 20231219 - Ultimovacs Notification of trade - CDS - KRT 1500
Comunicato Precedente
Comunicato Successivo
This information is subject to the disclosure requirements pursuant to the Market Abuse Regulation article 19 and section 5-12 of the Norwegian Securities Trading Act.
Attachment
- 20231219 - Ultimovacs Notification of trade - CDS - KRT 1500
Per maggiori informazioni
Sito Web
ultimovacs.com
Ufficio Stampa
Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
;
